Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation (Q44989307)

8 December 2017

Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation (English)

1 reference

8 December 2017

1 reference

8

1 reference

8 December 2017

Josep María Grinyo

1

1 reference

8 December 2017

José María Campistol

2

1 reference

8 December 2017

Javier Paul

3

1 reference

8 December 2017

Javier García-Martínez

4

1 reference

8 December 2017

José María Morales

5

1 reference

8 December 2017

Dolores Prats

6

1 reference

8 December 2017

Manuel Arias

7

1 reference

8 December 2017

José Cabrera

9

1 reference

8 December 2017

Enrique Granados

10

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

American Journal of Transplantation

8 December 2017

1 reference

8 December 2017

4

1 reference

8 December 2017

8

1 reference

8 December 2017

1308-1314

1 reference

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration

8 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Improved freedom from rejection after a loading dose of sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Post-transplant renal function in the first year predicts long-term kidney transplant survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00499.X

10.1111/J.1600-6143.2004.00499.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference